Skip to content
II
Public company · Nasdaq: IBIO

Updated:

iBio, Inc.

iBio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001420720, and its reported industry is...

Overview

iBio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001420720, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-08-28, it reported annual revenue of USD 100,000; net income of USD -33,044,000; total assets of USD 99,110,000 for the fiscal period ended 2026-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
iBio, Inc.
Former names in filing history
iBio, Inc. (2009-08-18 to 2026-10-13); iBioPharma, Inc. (2008-07-16 to 2009-08-14); InB:Biotechnologies, Inc. (2008-03-07 to 2008-07-17)
Classification
Public company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
New York, NY, United States
Incorporated in
DE
Fiscal year end
June 30
Ticker
Nasdaq: IBIO
SEC CIK
0001420720

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2026USD$100,000-$33.0M$99.1M$56.4M-$23.2M
FY2025USD$400,000-$18.4M$23.2M$8.6M-$15.3M
FY2024USD$225,000-$24.9M$28.7M$14.2M-$18.6M
FY2023USD$0—$41.2M$4.3M-$30.4M

FY2026. Net income: shown as originally filed; later filings report different values for the same periods.

FY2025. Net income: shown as originally filed; later filings report different values for the same periods.

FY2024. Net income: shown as originally filed; later filings report different values for the same periods.

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
DEF 14ADEF 14A
10-K10-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research iBio, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Public Company profiles

iBio, Inc. (Nasdaq: IBIO) — company profile | Altss